ReviewACS nano2026
Metal Halide Perovskites for Violet and Ultraviolet Light Emission.
Review in ACS nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emissive metal halide perovskites (MHPs) have emerged as candidates for next-generation optoelectronics due to their sharp color purity, inexpensive processing, and bandgap tunability. However, the development of violet and ultraviolet light-emitting MHPs has lagged behind due to challenges related to material and device stability, charge carrier transport, tunability into the ultraviolet spectrum, toxicity, and scalability. Here, we review the progress of both violet and ultraviolet MHP nanomaterials and light-emitting diodes, including materials synthesis and device fabrication across various crystal structures and dimensions (e.g., bulk thin films, 2D thin films, nanoplatelets, colloidal nanocrystals, and more) as well as lead-free platforms (e.g., rare-earth metal halide perovskites). By highlighting several pathways to continue the development of violet and ultraviolet light-emitting MHPs while also proposing tactics to overcome their outstanding challenges, we demonstrate the potential of violet and ultraviolet MHP materials and devices for important applications in public health, 3D printing, nanofabrication, and more.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.